Lv6
2080 积分 2022-07-05 加入
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
4天前
已完结
Aggressive hepatic vein resection aimed at achieving R0 resection for colorectal liver metastases remains crucial
5天前
已关闭
Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response
16天前
已完结
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study
1个月前
已完结
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer
1个月前
已完结
Pembrolizumab for Early Triple-Negative Breast Cancer
1个月前
已完结
Neoadjuvant pembrolizumab+chemotherapy/adjuvant pembrolizumab for Early-Stage Triple-Negative breast cancer: Quality-of-Life results from randomized KEYNOTE-522 study
1个月前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
1个月前
已完结
皖公网安备34019202002308
